Last reviewed · How we verify
2% Lidocaine HCl topical solution
At a glance
| Generic name | 2% Lidocaine HCl topical solution |
|---|---|
| Sponsor | Milton S. Hershey Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Bladder Directed vs. Pelvic Floor Therapy in IC/BPS (PHASE2)
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections (PHASE4)
- The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision (PHASE4)
- Cryotherapy as a Topical Anesthetic in Healthy Children (PHASE4)
- Topical Cryoanesthesia Versus Benzocaine in Pediatric Dentistry (PHASE3)
- Effect of Topical Lidocaine Spraying on the Vocal Cords Before Intubation During Robotic Surgery: a Randomized Controlled Trial (PHASE4)
- Efficacy of Microneedling With Vitamin C in Performing Gingival Depigmentation (PHASE1, PHASE2)
- Intrauterine Device Insertion Pain Management (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 2% Lidocaine HCl topical solution CI brief — competitive landscape report
- 2% Lidocaine HCl topical solution updates RSS · CI watch RSS
- Milton S. Hershey Medical Center portfolio CI